collection
MENU ▼
Read by QxMD icon Read
search

MM y Lenalidomide. Cambios en el tto. CROH, 2013.

shared collection
1 papers 0 to 25 followers
By Manuel Leonidas Rosales Acevedo M├ędico hematologo
https://www.readbyqxmd.com/read/23816163/how-lenalidomide-is-changing-the-treatment-of-patients-with-multiple-myeloma
#1
REVIEW
Meletios A Dimopoulos, Evangelos Terpos, Ruben Niesvizky
Lenalidomide is a distinct second-generation immunomodulatory drug with multiple anticancer and immunomodulatory effects against hematologic malignancies, in particular multiple myeloma (MM). Dexamethasone synergistically enhances the anticancer effects of lenalidomide, and the combination of lenalidomide and dexamethasone (Len/Dex) is approved for the treatment of patients with relapsed and/or refractory MM. Results from pivotal phase III trials in this setting have demonstrated that Len/Dex extends overall survival compared with dexamethasone alone...
October 2013: Critical Reviews in Oncology/hematology
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"